MedBodh Clinical Drug Preparation | Updated 4 November 2026. Professional reference; verify local brand-specific prescribing information and hospital protocol before bedside administration.
CLINICAL SAFETY NOTICE (5 Nov 2026): Educational overview only, not a validated bedside preparation chart. Verify exact dose, dilution, rate, compatibility, stability, renal/hepatic adjustments and paediatric use against the specific product label, current institutional protocol and pharmacist. Do not infer dosing from this page alone.
Clinical indications and strengths
Norepinephrine is a vasopressor for severe hypotension after assessment and appropriate resuscitation. A manufacturer-labelled ready-to-use product contains 4 mg/250 mL (16 micrograms/mL), 8 mg/250 mL (32 micrograms/mL), or 16 mg/250 mL (64 micrograms/mL) in dextrose or saline; these ready-to-use bags need no further dilution. Concentrated ampoules are NOT interchangeable with premixed bags: follow their own approved dilution instructions.
Preparation and administration workflow
- Verify patient identity, indication, allergy history, body weight where applicable and prescriber’s order.
- Read actual vial/bag concentration and distinguish salt strength from active-base equivalent where relevant.
- Check manufacturer-authorised diluent, final concentration, compatibility, route, infusion pump and beyond-use time.
- Perform independent high-alert medication double-check and label every prepared syringe/bag.
- Document preparation, administration, monitoring and any adverse reaction.
Emergency safety, nursing monitoring and special populations
Use a controlled infusion pump with frequent BP checks, ECG, perfusion/urine-output monitoring and careful IV-site surveillance. Prefer appropriate central access when feasible; extravasation requires immediate institutional management. Avoid mixing with alkaline solutions, iron salts or oxidants. Titrate to the treating team’s haemodynamic target, never by an unverified fixed drop rate. Review fluid status, arrhythmias and peripheral ischaemia.
Adult and paediatric dosing
There is no single safe universal dose: dosing varies by indication, age/weight, organ function, formulation and clinical response. Use the linked full product label and the current hospital emergency algorithm rather than extrapolating one preparation to every scenario.
Contraindications, interactions and common errors
Review the product-specific label, comorbidities, concurrent medicines and IV compatibility. Do not mix drugs in the same line without verified compatibility. Escalate immediately for suspected medication error or adverse drug reaction.
Primary manufacturer label
DailyMed: current official product labelling. Indian brands can differ in concentration, excipients and authorised routes; verify the locally stocked ampoule.